Tweet
For those in the MAP program (or otherwise), how much does a MinIon flowcell cost? I saw somewhere that there is only a refundable deposit for the program, and in another place that it costs $1000 per flowcell. Would like to hear what the actual participants are paying to access a MinIon. Are reagents a separate cost, or can you use your own favorite reagents for sample prep?
-
-
While we haven't used the MinION ourselves, ONT spells out the costs here: https://nanoporetech.com/community/specifications
Look like it's $1000 to start, which includes the instrument and enough reagents/flow cells for two runs (used to be three runs). Additional flow cells cost $270-$900 (depending on how many you buy) and $99 for the reagents for each run. Not sure if that covers any sample prep or if that's just the cost to run the flow cell.
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment